Clinical Trial Update: The HIV Functional Cure Potential of UB-421 in ART Stabilized HIV-1 Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating UB-421 for functional cure potential in ART-stabilized HIV-1 patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• UB-421 (anti-CD4 antibody)

Snippet

Sponsor: UBP Greater China (Shanghai) Co., Ltd | Conditions: HIV-1-infection | Phase 2 | Status: UNKNOWN